Chronic heart failure is a complex clinical syndrome with impaired myocardial contractility. In failing cardiomyocytes, decreased signalling efficiency between the L-type Ca 2+ channels (LCCs) in the plasma membrane (including transverse tubules, TTs) and the ryanodine receptors (RyRs) in the sarcoplasmic reticulum (SR) underlies the defective excitation -contraction (E-C) coupling. It is therefore intriguing to know how the LCC -RyR signalling apparatus is remodelled in human heart failure.
Introduction
Heart failure is the final stage of cardiac remodelling caused by hypertension, ischaemia, cardiomyopathy, and other chronic factors. 1 Although numerous cellular and molecular changes have been identified in failing hearts, 1 -6 a key symptom that threatens patients' lives is the decreased myocardial contractility. 7 The contraction of the heart is initiated via the excitation -contraction (E-C) coupling process, in which voltage-gated L-type Ca 2+ channels (LCCs) in the plasma membrane and transverse tubules (TTs) activate Ca 2+ release from ryanodine receptors (RyRs) in the sarcoplasmic reticulum (SR) and initiate cell contraction. 8 -11 Ultrastructural studies showed that the junctional SR meets the TT across a 15 nm cleft, forming a Ca 2+ signalling structure known as a dyad. 12 Studies in rodent models have shown that the volume densities of junctional SRs and SR-coupled TTs were both decreased in failing heart cells. 13 The TT -SR junctions were displaced or missing from the Z-line areas. 13 Moreover, the spatial span of individual TT-SR junctions was markedly reduced in failing heart cells. 13 The shrinkage and eventual absence of TT -SR junctions have been proved to be important mechanisms underlying the desynchronized and inhomogeneous Ca 2+ release and the decreased contractile strength in rodent models. 13 The maintenance of TT -SR dyadic junction is found to rely on a family of proteins known as junctophilin.
14 Junctophilin has multiple membrane recognition nexus motifs and an SR transmembrane † These authors contributed equally.
region that anchors SR membranes to TTs across a 15 nm junctional cleft. 12 Junctophilin-2 (JP2) is the cardiac-specific isoform of junctophilin, 15 and its expression is found decreased in rodent models of failing heart cells. 16 -18 Knockdown of JP2 indeed reproduced the structural and functional remodelling of E-C coupling. 13,18 -20 Therefore, the defective signalling between LCCs and
RyRs is attributed to the down-regulation of JP2. Most of the above studies have been based on rodent models of hypertrophy and heart failure. In human heart failure, many studies have shown profound ultrastructural remodelling in TTs. 21 -25 However, how the structure of LCC -RyR signalling microdomain is changed in different types of human heart failure and whether the remodelling comes with altered JP2 expression still call for in-depth investigation. In the present study, we utilized the transmission electron microscopy (TEM) technology to characterize the ultrastructural modification of TT-SR junctions in heart failure specimens of dilated cardiomyopathy (DCM) and ischaemic cardiomyopathy (ICM). We found that human heart failure of distinct causes shared quite similar remodelling in TT -SR junctional structure and downregulation of JP2 expression.
Methods

Human specimens
Studies involving human tissues complied with the Helsinki Declaration of the World Medical Association and were approved by Peking University Ethical Review Board (IRB00001052-08034). For ultrastructural and biochemical analysis, left-ventricular wall samples were obtained from explanted end-stage failing hearts from transplant recipients (eight DCM patients of 41.1 + 5.3 years old and five ICM patients of 56.4 + 4.9 years old). Small pieces of left ventricle tissues from four adults of accidental traumatic brain-death (35.0 + 4.6 years old), who had no medical evidence of cardiac disease, were used as reference.
TEM and stereological measurement
Heart tissues were first fixed in 2.5% glutaraldehyde and 1% paraformaldehyde in 0.1 M PBS buffer (pH 7.4). After rinsing three times with 0.1 M PBS buffer, the samples were post-fixed in a mixture of 0.8% potassium ferrocyanide and 2% osmium tetroxide in 0.1 M sodium cacodylate buffer for 2 h. After dehydration in a graded series of acetone, the samples were embedded in Spurr resin and sectioned with a glass knife on a Leica Ultracut R cutter. Thin sections were stained with uranyl acetate and lead citrate, then observed and randomly imaged under an FEI Tecnai G 2 20 Twin system. For stereological measurement of the volume densities and surface areas of TTs and JSRs, we followed Mobley's stereological method. 26 In brief, the volume density was calculated as the percentage of interested volume component (V i ) in all the tested volume (V test ) by V i /V test = P i /P test , where P i is the number of grid points that fell within the component of interest, and P test is the total number of grid points in tested areas. The surface area of interest (S i ) in a tested volume (V test ) was calculated as
where C i is the number of intersections between the grid and interested membrane structures and d is the distance between parallel lines in the grid.
JP2 mRNA and miR-24 expression assays
Total RNA was extracted from cardiac tissue using Trizol reagent (Invitrogen) according to the manufacturer's instructions. For reverse transcription of total RNA, 2 mg total RNA was added to a 50 ml reaction system containing oligo-dT(15), dNTP, RNAse OUT, and Superscript III reverse transcriptase (Invitrogen), and incubated for 1 h at 508C. For miR-24 quantification, the first strand cDNA was first synthesized by microRNA-specific reverse-transcription primers (RiboBio Co., Ltd). To assess the expression of JP2 mRNA or miR-24, 10 ng cDNA product was used for real-time PCR amplification using Brilliant II SYBR Green QPCR master mix (Stratagene), and the fluorescent signals were monitored by an Mx3000p real-time PCR system (Stratagene). The thermocycling program was set as: 958C for 10 min, followed by 40 cycles at 958C for 15 s, 608C for 30 s, and 728C for 30 s, and finally an additional dissociation step to ensure the specificity of amplification. The primers for microRNA sample amplification were provided by RiboBio Co., Ltd, and the primers for JP2 and GAPDH were: Human JP2 (forward: 5 ′ -ATG GGC TGG GCA TAG AGA C-3 ′ ; reverse: 5 ′ -TTG AAG CCA TGT GTC CAC TC-3 ′ ); and Human GAPDH (forward: 5 ′ -AGC TGA ACG GGA AGC TCA CT-3 ′ ; reverse: 5 ′ -TAG GTC CAC CAC TGA CAC GTT G-3 ′ ). GAPDH was used as control for JP2 mRNA quantification, and the small nuclear RNA U6 was used as control for microRNA quantification.
Western blot
Heart tissues from human left ventricles were homogenized in lysis buffer containing 1% sodium deoxycholate, 10 mM Na 4 P 2 O 7 , 1% Triton-100, 10% glycerol, 150 mM NaCl, 5 mM EDTA . Na 2 , 20 mM Tris (pH 7.4), 0.1% SDS, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM PMSF, and protease inhibitor cocktail (Roche). The sample lysate was separated on 10% SDS -PAGE and then transferred to PVDF membrane. Membranes were incubated with self-made rabbit polyclonal antibody against JP2 (1 mg/ml), which specifically recognized the JP2 p434-p447 peptide (QEI-LENSESLLEPR). A horseradish peroxidase-conjugated GAPDH antibody (KangChen Bio-tech Inc., China) was used to measure the GAPDH content as loading control.
Statistical analysis
Results are expressed as mean + SE. Statistical analysis was performed, where appropriate, using Student's t-test and the Mann-Whitney rank sum test. Multiple comparisons were adjusted using Bonferroni correction. A value of P , 0.05 was considered significant.
Results
Transmission electron microscopic (TEM) images were taken randomly to examine the TT-SR dyadic junctions (white squares and inserts in Figure 1A ) in left-ventricle specimens from DCM and ICM heart failure patients during transplantation surgery and from agematched ostensibly healthy adults after traumatic brain-death (Control). We found that the number of TTs per unit area ( Figure 1B ) and the percentage of TTs coupled with SRs ( Figure 1C ) were significantly lower in both DCM and ICM groups compared with the Control group. These two factors led to a .60% decrease in the number of TT-SR junctions per unit area in both heart failure groups ( Figure 1D ).
To quantify the morphological changes objectively and accurately, we used classic stereological analysis 26 to measure volume densities and surface areas of coupling structure between TTs and SRs ( Figure 2A) . Compared with that in the Control group, the volume density of TTs was reduced by 40% in DCM and ICM heart tissues ( Figure 2B ). This reduction reflected the detachment between TTs and SRs, because the volume density of SR-coupled TTs was similarly reduced in both DCM and ICM groups while that of TTs apparently not coupled to SRs was unchanged or even increased. As a result, the volume density of junctional SRs was reduced by 45.9 and 50.6%, respectively, in DCM and ICM groups.
Statistics of the surface area of TTs, SR-coupled TTs, and junctional SRs showed similar pattern of changes ( Figure 2C ). We noted that the TT-SR junctions, which usually appear regularly at Z-lines in the Control group, were missing from many of the 'due' areas in heart failure tissues ( Figure 1A) . To quantify this change, we measured the presence rate of TTs and TT-SR junctions in the non-myofilament areas between two adjacent M-lines (inter-M areas, Figure 3A) . We found that the percentage of inter-M areas that displayed TTs was dramatically decreased in both DCM and ICM groups ( Figure 3B ). As the percentage of TTs that coupled with SRs was also decreased ( Figure 1C) , the percentage of inter-M areas that displayed TT-SR junctions was reduced even more dramatically ( Figure 3C ).
For those inter-M areas that displayed TT-SR junctions, the positioning of junctions was also modified. The perpendicular distance from the centre of a TT-SR junction to its adjacent Z-line ( Figure 4A ) was significantly increased in both DCM and ICM groups ( Figure 4B) , with their distributions shifted to longer distances ( Figure 4C ).
Our recent work showed that the spatial span of individual TT -SR junctions is an important factor in determining the efficiency of E-C coupling. 13 Measurements of the apparent curvilinear length of parallel TT and SR membranes (yellow line in Figure 5A ) showed that the junction size was 17% smaller in DCM and ICM groups than in the Control group ( Figure 5B) , with the peak of its distribution shifted to smaller size ( Figure 5C ). The 17% decrease in junction length would predict a 30% decrease in junction size or RyR number per junction.
13
Maintenance of the TT-SR dyadic junction relies on JP2. 13, 14, 20 To determine whether JP2 down-regulation characterizes different types of human heart failure, we assessed JP2 expression in human left-ventricle specimens. Real-time PCR assays showed that JP2 was indeed significantly down-regulated in both DCM and ICM groups ( Figure 6A ). Western blot assays confirmed that JP2 was down-regulated at the protein levels in both heart failure groups ( Figure 6B) . Recently, we found that JP2 is regulated by miR-24, a microRNA up-regulated in rodent models of heart failure. 27 In order to know whether miR-24 is modulated in human heart failure, we analysed the expression of miR-24. We found that microRNA-24 expression was increased by approximately two-folds in DCM and ICM groups ( Figure 6C ). Because in vivo suppression of miR-24 is able to prevent the TT-SR remodelling and protect the E-C coupling performance, 28 we believe that the up-regulation of miR-24 and downregulation of JP2 have mechanistic implications in the ultrastructural and functional remodelling in human heart failure.
Discussion
TT-SR junction is the structural basis for Ca 2+ -induced Ca 2+ release
and E -C coupling in cardiomyocytes. 12 The LCC -RyR signalling across the TT-SR junctional cleft determines the contractile strength of the heart. 17 Therefore, examining the detailed structural remodelling of the Ca 2+ signalling apparatus is essential for elucidating the mechanisms underlying the defective E-C coupling in heart failure. In the present study, using TEM morphometric analysis, we systematically quantified the ultrastructural remodelling of TT-SR junctions that governs the LCC -RyR Ca 2+ signalling in human failing myocardium from DCM and ICM patients. We found that, in both DCM and ICM failing myocardium: (i) the volume densities and surface areas per unit volume of junctional SRs and SR-coupled TTs were dramatically decreased, agreeing well with the decreased densities of TTs and TT-SR junctions per unit area; (ii) the TT-SR junctions were displaced or missing from many of the Z-line areas; (iii) the spatial span of individual TT-SR junctions was markedly reduced; (iv) JP2 expression was down-regulated; and (v) miR-24, which suppresses JP2 expression, 27 was up-regulated. Compared with similar studies in the aorta-constrained rat heart failure model, 13 human heart failure comes with relatively moderate shrinkage in individual TT-SR junction size but much more reduction in total TT -SR junctions. The identification of miR-24 up-regulation and JP2 down-regulation in different types of human heart failure provides mechanistic interpretation for the ultrastructural remodelling of the TT -SR junctions.
Morphological changes of TTs in hypertrophy and heart failure
In 1970s, the application of stereological quantification of intracellular membranous structures 29, 30 promoted the ultrastructural study of cardiac myocytes during hypertrophy and heart failure. Anversa et al. 31 demonstrated in rabbit myocardium with experimental advanced hypertrophy that the TT system was dilated. This phenomenon was then observed in other animal models of hypertrophy 32, 33 and heart failure. 34 Later on, dilated TTs were also found in human heart tissues of hypertrophic cardiomyopathy, congestive cardiomyopathy, dilated cardiomyopathy, ischaemic cardiomyopathy, aortic valvular disease, and congenital heart diseases associated with obstruction to right-ventricular outflow. 24 Therefore, dilation of TTs is a common feature of cardiac ultrastructural remodelling during hypertrophy and heart failure. However, despite the dilation of TTs, the number of TTs per unit area is markedly decreased in many animal models and human specimens of hypertrophy and heart failure. 22, 35 Therefore, the change of total TT surface would depend on the dominance of these two counteracting factors. Indeed, it has been shown that the volume and surface area of TTs are increased in animal models of cardiomyopathy, 36 spontaneous hypertension, 37 thyroxinestimulated hypertrophy, 38 and hypertension/hypertrophy induced by constriction of aorta or arteries. 39, 40 Most of these models are in the compensated stage. In late stage of pressure-overload hypertrophy or heart failure models, in contrast, the volume and surface area of TTs are reduced. 13 These ultrastructural results agree well with recent optical imaging studies, in which significant loss of TT density and disorganization of TT network were detected in a variety of animal models and human specimens of heart failure. 6,18,21,23,35,41 -46 In human heart failure, our present study showed that the volume density and surface area of TTs were reduced by 40% in both DCM and ICM specimens. This percentage of reduction was higher compared with that in failing heart cells of rat models. 13 Given that TTs are invaginations from cell membranes, the reduction of TTs may reflect either a shortening or a 'pluck-off' of the invaginations. A recent study using scanning ion conductance microscopy has shown that the TT holes on the cell surface are significantly reduced in human specimens of heart failure, 45 indicating that many of the TTs are plucked-off from the cell membrane, although shortening of TTs is still reasonably expected.
Remodelling of TT -SR junctions
In cardiac cells, SR meets TT with a 15 nm junctional cleft, forming a dyadic structure enabling the local control of Ca 2+ -induced Ca 2+ release. 12 Similar to the remodelling patterns of TTs, the volume and surface area of SRs (or smooth endoplasmic reticulum) in heart cells are increased in hypertrophy. 22, 36, 40, 47 It seems that TTs and SRs adapt themselves to enlarged cell size mainly by swelling during the compensated hypertrophy stage. However, in the decompensated/failing stage, the TT surface area is reduced, and the junctional SR is also reduced. 13 Our present study confirmed that the volume density and surface area are reduced in human heart failure of different causes. Taken together, the remodelling of TT and SR structure occurs as early as compensated hypertrophy. While the TT and SR surfaces are increased in the compensated stages, they are decreased in the decompensated/ failing stage. Although many studies have characterized TT and SR structure in a variety of animal models and human specimens of heart failure, few studies quantified the remodelling of individual TT-SR couplons. Our recent work in rat heart failure models shows that the TT -SR junctions are displaced or missing from the Z-line areas. Moreover, the spatial span of individual TT-SR junctions is markedly reduced in failing heart cells. 13 In the present study, we extended the quantification of TT-SR junction to human specimens. Our results showed that similar ultrastructural remodelling of TT-SR junctions occurred in both DCM and ICM failing hearts. Compared with the changes in rat failing cells, although the percentage of junction size reduction is relatively moderate in human heart failure, the loss of TTs at their 'due' positions was much more pronounced. The shrinkage and eventual loss of TT-SR junctions are among important mechanisms underlying the desynchronized/inhomogeneous Ca 2+ release and the decreased contractile strength in failing heart cells.
Role of JP2 and miR-24 in E -C coupling remodelling
JP2 is a structural protein linking SR to cell membrane/TTs, 14 and plays a key role in the nanoscopic signalling between LCCs and RyRs during E-C coupling. 13, 14, 19, 20 In all heart failure models characterized so far, including in DCM and ICM specimens measured in the present study, JP2 expression is down-regulated without exception. 13,16 -19,27,46 Recent studies also show that JP2 mutations are associated with human hypertrophic cardiomyopathy. 48, 49 Since JP2 knockdown turns to disrupt the TT system, reduce the volume density, and spatial span of TT-SR junctions, and decrease the efficiency of E-C coupling, 13,18 -20 the down-regulation of JP2 is potentially a common mechanism underlying the defective E-C coupling in heart failure of different causes. Given the determinant role of JP2 in forming the LCC -RyR signalling structure, to keep the E-C coupling in a healthy status, the JP2 level must be finely tuned within a certain dynamic range. Recent study shows that transgenic over-expression of JP2 rescues the effects of JP2 knockdown on TTs, junctional SRs, and E-C coupling performances. 20 Now, the only endogenous mechanism known to regulate JP2 expression is miR-24, which suppresses JP2 expression by binding to the 3 ′ -untranslated region of JP2 mRNA. 27 In vivo suppression of miR-24 stabilizes JP2 expression and prevents the reductions in TTs, junctional SRs, and E-C coupling gain in cardiomyocytes from aortic-constricted mice. 28 Future exploration of the transcription control system of JP2, which counteracts the post-transcriptional regulation by the microRNA system, is important in elucidating the molecular mechanisms underlying the structural remodelling of TT-SR junctions. Given that miR-24 is up-regulated in failing heart cells 27 and that in vivo suppression of miR-24 prevents the transition from hypertrophy to heart failure, 28 developing therapeutic treatments that target miR-24 and JP2 expression systems will be a new strategy against heart failure.
